Point72 Asset Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Point72 Asset Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-3,815,806	Closed	-$43.4M	–	2559
2024 Q3	$43.4M	Buy	3,815,806 +1,142,756	+43%	+$11.5M	0.11%	213
2024 Q2	$19.1M	Buy	2,673,050 +904,733	+51%	+$6.92M	0.05%	413
2024 Q1	$11.8M	Buy	1,768,317 +1,258,486	+247%	+$8.66M	0.03%	653
2023 Q4	$3.31M	Buy	509,831 +314,757	+161%	+$2.03M	0.01%	1059
2023 Q3	$1.84M	Buy	+195,074	New	+$2.35M	0.01%	1155
2022 Q4	–	Sell	-480,490	Closed	-$9.19M	–	1853
2022 Q3	$9.19M	Buy	480,490 +351,890	+274%	+$6.41M	0.04%	529
2022 Q2	$1.96M	Sell	128,600 -182,639	-59%	-$2.7M	0.01%	942
2022 Q1	$6.34M	Buy	+311,239	New	+$6.34M	0.03%	637
2021 Q4	–	Sell	-308,780	Closed	-$6.66M	–	1348
2021 Q3	$6.66M	Buy	308,780 +21,480	+7%	+$519K	0.03%	598
2021 Q2	$7.37M	Buy	+287,300	New	+$6.14M	0.03%	522
2021 Q1	–	Sell	-89,563	Closed	-$1.03M	–	1220
2020 Q4	$1.03M	Buy	+89,563	New	+$819K	0.01%	805

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

PAIM

Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Point72 Asset Management's CDMO Position: Q4 2024 in Review

Point72 Asset Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2024, closing a stake of 3,815,806 shares — an estimated $43.4M sold.

Point72 Asset Management first reported a position in CDMO in Q4 2020 and held it in 11 quarters. The position peaked at $43.4M in Q3 2024. 195 funds tracked by Wall St. Rank hold CDMO as of Q4 2024.

Point72 Asset Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Point72 Asset Management sold 3,815,806 Avid Bioservices, Inc. Common Stock shares in Q4 2024, an estimated $43.4M.
Point72 Asset Management first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2020 and held it in 11 quarters.
Point72 Asset Management's Avid Bioservices, Inc. Common Stock position peaked at $43.4M in Q3 2024.
195 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2024.

Based on Point72 Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.